Circulating BRAF(V600E) Levels Correlate with Treatment in Patients with Thyroid Carcinoma

Background: BRAF(V600E) is the most common mutation in papillary thyroid carcinoma (PTC) and can be associated with aggressive disease. Previously, a highly sensitive blood RNA-based BRAF(V600E) assay was reported. The objective of this study was to assess the correlation of BRAF(V600E) circulating...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thyroid
Main Authors: Lubitz, Carrie C., Zhan, Tiannan, Gunda, Viswanath, Amin, Salma, Gigliotti, Benjamin J., Fingeret, Abbey L., Holm, Tammy M., Wachtel, Heather, Sadow, Peter M., Wirth, Lori J., Sullivan, Ryan J., Panka, David J., Parangi, Sareh
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2018
Assuntos:
Thyroid Cancer and Nodules
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865613/
https://ncbi.nlm.nih.gov/pubmed/29378474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2017.0322
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados